Director Leslie B. Daniels filed a Form 4 with the U.S. Securities and Exchange Commission on August 6, 2026, reporting the acquisition of restricted common stock shares in Anterix Inc. (NASDAQ: ATEX) on August 4, 2026.

Key Highlights

  • Shares acquired: Leslie B. Daniels acquired 1,598 shares of Anterix Inc. common stock on August 4, 2026, at a price of $0.
  • Transaction code: The transaction was coded "A" (acquisition), reported under Table I for non-derivative securities.
  • Vesting condition: According to the filing, the shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.
  • Direct holdings after transaction: Following the reported transaction, Daniels directly beneficially owned 56,077 shares of common stock.
  • Indirect holdings: The filing also reports 2,000 shares held indirectly by IRA and 5,000 shares held indirectly by 401K.
  • Relationship to issuer: Daniels is identified as a Director of Anterix Inc.

Anterix Director Leslie B. Daniels Reports Restricted Stock Grant

According to the Form 4 filed on August 6, 2026, Leslie B. Daniels, a director of Anterix Inc. (NASDAQ: ATEX), acquired 1,598 shares of the company's common stock on August 4, 2026. The transaction was recorded at a price of $0, consistent with a restricted stock award rather than an open-market purchase. The filing indicates no derivative securities were involved in the reported transaction.

The filing discloses that the acquired shares are subject to a Restricted Stock Agreement and "will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027," as stated in the explanation of responses. Following this acquisition, Daniels directly held 56,077 shares of Anterix common stock, according to the filing.

In addition to direct holdings, the filing reports that Daniels indirectly holds 2,000 shares through an IRA and 5,000 shares through a 401K account. The Form 4 was signed by Gena L. Ashe as Attorney-in-Fact on August 6, 2026. No amendment date was listed, indicating this is an original filing.

What Was Disclosed

The filing reports a restricted stock acquisition of 1,598 shares by Anterix Inc. director Leslie B. Daniels on August 4, 2026, at $0, bringing direct beneficial ownership to 56,077 shares, with an additional 7,000 shares held indirectly through retirement accounts.